Work

High-affinity FRβ-specific CAR T cells eradicate AML and normal myeloid lineage without HSC toxicity

Year: 2016

Type: article

Source: Leukemia

DOI: 10.1038/leu.2016.35

Authors: R C Lynn, Y Feng, K Schutsky, M Poussin, A Kalota, D S Dimitrov, D J Powell Jr

Institutions: University of Pennsylvania, National Cancer Institute, Center for Cancer Research, Abramson Cancer Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Pennsylvania, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases

Awards: Training in Vaccine & Immune Therapeutics, A Universal Approach to Personalized Adoptive T cell Therapy of Cancer

OpenAlex ID: W2288029921

FWCI: 7.541

Cites: 41

Cited by: 123

Related to: 10